| Biomedical | Anthropometric | |||
|---|---|---|---|---|
| Reduction in blood sugar (hgbA1C)2 Diabetes prevention / reversal | -0.91 pts | Average weight loss: Total6 (-4.9% initial body weight) | -8.9 lbs | |
| Reduction in inflammation (hsCRP)3 Precursor to cancer, chronic disease, arthritis | -1.3 pts | Average weight loss: Normal BMI7 (-4.2% initial body weight) | -6.1 lbs | |
| Reduction in elevated cholesterol (LDL)4 CVD, stroke, heart disease, high blood pressure | -41 pts | Average weight loss: Overweight BMI8 (-5.1% initial body weight) | -9.2 lbs | |
| Waist circumference reductions5 Visceral fat, obesity, NAFLD | -2.0" | Average weight loss: Obese BMI9 (-5.1% initial body weight) | -11.3 lbs | |
These results formed the basis for the randomized control trials for evaluating cancer risk reduction
1 Based upon Plantable's 28-day Reboot. Results collected from May 2015, January 2016 - September 2017 
|
||||
